87 related articles for article (PubMed ID: 15498386)
1. Specific cytotoxic T lymphocyte responses in Chinese HIV/AIDS patients.
Shang H; Han XX; Wang YN; Zhou LP; Zhang ZN; Jiang YJ; Zhang M; Yu X
Chin Med J (Engl); 2004 Oct; 117(10):1570-2. PubMed ID: 15498386
[No Abstract] [Full Text] [Related]
2. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
Kawashima Y; Satoh M; Oka S; Shirasaka T; Takiguchi M
Biochem Biophys Res Commun; 2008 Feb; 366(3):612-6. PubMed ID: 18035044
[TBL] [Abstract][Full Text] [Related]
3. HIV and children: the developing immune system fights back.
Feeney ME
West Indian Med J; 2004 Oct; 53(5):359-62. PubMed ID: 15675505
[TBL] [Abstract][Full Text] [Related]
4. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
Zhang HW; Qiu ZF; Li TS
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
[TBL] [Abstract][Full Text] [Related]
5. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
[TBL] [Abstract][Full Text] [Related]
6. Influenza and its vaccination in HIV1-AIDS patients.
Mathé G
Biomed Pharmacother; 2000 May; 54(4):175-7. PubMed ID: 10872715
[TBL] [Abstract][Full Text] [Related]
7. The lucky ones. How do some HIV-positive people avoid getting AIDS?
Beardsley T
Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
[No Abstract] [Full Text] [Related]
8. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
9. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
10. Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese.
Liu HW; Hong KX; Ma J; Yuan L; Liu S; Chen JP; Zhang YZ; Ruan YH; Xu JQ; Shao YM
Chin Med J (Engl); 2006 Oct; 119(19):1616-21. PubMed ID: 17042974
[TBL] [Abstract][Full Text] [Related]
11. Immune impairment thresholds in HIV infection.
Iwami S; Nakaoka S; Takeuchi Y; Miura Y; Miura T
Immunol Lett; 2009 Apr; 123(2):149-54. PubMed ID: 19428563
[TBL] [Abstract][Full Text] [Related]
12. HIV recent advances in AIDS research: genetics, molecular biology and immunology.
Landau NR
Curr Opin Immunol; 1999 Aug; 11(4):449-50. PubMed ID: 10448145
[No Abstract] [Full Text] [Related]
13. HIV-specific T cell immunity across the entire HIV genome in Chinese men who have sex with men.
Zhang XY; Huang XG; Xu JQ; Li SW; Jiang SL; Zhang XX; Li DL; Ruan YH; Xing H; Shao YM
Chin Med J (Engl); 2006 Dec; 119(23):1958-65. PubMed ID: 17199939
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte phenotypes in patients with highly reduced T inducer to T cytotoxic/suppressor ratio.
Herrmann F
Clin Exp Immunol; 1984 May; 56(2):476-8. PubMed ID: 6234115
[No Abstract] [Full Text] [Related]
15. A winding road towards an HIV vaccine.
Rowland-Jones S
Eur J Immunol; 2008 Jan; 38(1):13-4. PubMed ID: 18286707
[No Abstract] [Full Text] [Related]
16. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
Cristillo AD; Lisziewicz J; He L; Lori F; Galmin L; Trocio JN; Unangst T; Whitman L; Hudacik L; Bakare N; Whitney S; Restrepo S; Suschak J; Ferrari MG; Chung HK; Kalyanaraman VS; Markham P; Pal R
Virology; 2007 Sep; 366(1):197-211. PubMed ID: 17499328
[TBL] [Abstract][Full Text] [Related]
18. Heightened T-cell proliferation without an elevation of CD4+ T cell spontaneous apoptosis in AIDS patients.
Li H; Huang X; Guo C; Wang W; Li Z; Zhang T; Peng Q; Chen X; Wu H
Clin Immunol; 2008 Dec; 129(3):499-508. PubMed ID: 18835751
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
20. [Influencing factors of single-platform method of flow cytometry in the detection of immunophenotype of peripheral blood lymphocytes in HIV/AIDS patients].
Zhang FJ; Yao J; Zhao HX; Feng X; Lu LH; Han N; Liu ZY; Lin H
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):124-6. PubMed ID: 15774223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
